Differential helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 2, 1999, Pages 120-125

  Wong, B C Y ^a   Lam, S K ^a   Ching, C K ^a   Hu, W H C ^a   Kwok, E ^a   Ho, J ^a   Yuen, S T ^a   Gao, Z ^b   Chen, J S ^c   Lai, K C ^a   Ong, L Y ^a   Chen, B W ^d   Wang, W H ^d   Jiang, X W ^e   Hou, X H ^f   Lu, J Y ^g   Lin, C Q ^h   Wu, J P ^h   Chen, X C ^h   Lin, Z C ^h   Chong, M ^h   Fan, Y C ^h   Lee, H S ^h   Wong, K W ^h   Tang, S Y ^h   Lee, M Y ^h   Tsang, C ^h   Wong, A ^h   more..

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Public Health Bureau   (China)

^c Fujian Changle Inst for Cancer R   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^g DONGGUAN PEOPLE'S HOSPITAL   (China)

^h Department of Medicine People's Hospital of Dongguan City ^*

Author keywords

Gastric cancer; HeIicobacter pylori; South China

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CHINA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HONG KONG; HUMAN; HUMAN TISSUE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0032934172     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01823.x     Document Type: Article

References (41)

1. 1 Forman D, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. Br. Med. J. 1991; 302: 1302-5.
2. 2 Normura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 1991; 325: 1132-6.
3. 3 Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991; 325: 1127-31.
4. 4 Forman D, Webb P, Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994; 343: 243-4.
5. 5 Talley NJ, Zinsmeister AR, Weaver A et al. Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl Cancer Inst. 1991; 83: 1734-9.
6. 6 Sipponen P, Kosunen TU, Valle J, Riihela M, Seppala K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J. Clin. Pathol. 1992; 45: 319-23.
7. 7 Kang HC, Chung IS. Helicobacter pylori infection and gastric adenocarcinoma in Korea: Prevalence and distribution of Helicobacter pylori in resected specimen of gastric cancer. Korea Cathol. Med. Coll. 1992; 45: 849-62.
8. 8 Hansson L, Engstrand L, Nyren O et al. Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098-103.
9. 9 Blaser MJ, Kobayashi K, Clover TL, Cao P, Feurer ID, Perez-Perez GI. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int. J. Cancer 1993; 55: 799-802.
10. 10 Lin JT, Wang JT, Wang TH, Wu MS, Lee TK, Chen CJ. Helicobacter pylori infection in a randomly selected population, healthy volunteers and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan. Scand. J. Gastroenterol 1993; 28: 1067-72.
11. 11 Kuipers EJ, Gracia-Casanova M, Pena AS et al. Helicobacter pylori serology in patients with gastric carcinoma. Scand. J. Gastroenterol. 1993; 28: 433-7.
12. 12 Estevens J, Fidago P, Tendeiro T et al. Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: Report of a case-control study. Eur. J. Cancer Prev. 1993; 2: 377-80.
13. 13 Archimandritis A, Bitsikas J, Tjivras M et al. Non-cardia gastric adenocarcinoma and Helicobacter pylori infection. Ital. J. Gastroenterol. 1993; 25: 368-71.
14. 14 Correa P, Fox J, Fontham E et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569-74.
15. 15 Sierra R, Munoz N, Pena AS et al. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: Comparison of two areas with different risks for gastric cancer. Cancer Epidemiol. Prev. 1992; 1: 449-54.
16. 16 Buiatti E, Palli D, Amadori D et al. Methodological issues in a multicentric study of gastric cancer and diet in Italy: Study design, data sources and quality controls. Tumori 1989; 75: 410-19.
17. 17 Palli D, Decarli A, Cipriani F et al. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol. Biomarkers Prev. 1993; 2: 37-40.
18. 18 Lin HZ, Zhang YC, Zhang WF, Bai XW. Campylobacter pyloridis (Cp) infection of gastric mucosa in the high and low risk areas of gastric cancer in Liaoning Province. Chim. J. Oncol. 1989; 11: 365-7.
19. 19 Fukao A, Komatsu S, Tsubono Y et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: A cross-sectional study. Cancer Causes Control 1993; 4: 307-12.
20. 20 Tsugane S, Kabuto M, Imai H et al. Helicobacter pylori, dietary factors and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993; 4: 297-305.
21. 21 Forman D, Sitas F, Newell DG et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int. J. Cancer 1990; 46: 608-11.
22. 22 The EuroGast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
23. 23 Medical Directory of Hong Kong. Hong Kong: Federation of Medical Societies of Hong Kong, 7th edn, 1992.
24. 24 Chen JS, Chen W, Gao Z et al. Gastric cancer mortality trend between 1973 and 1990 in Changle. Fujian Med. Coll. J. 1992; 26: 116-18.
25. 25 Gao Z, Chen JS, Lin CC, Lin ZC, Ng JP. Analysis of gastric cancer incidence between 1989 and 1991 in Changle. Fujian Med. Coll. J. 1992; 26: 114-15.
26. 26 Ching CK, Buxton C, Holgate C, Holmes GKT. Cytological brushing urea broth test: A highly sensitive and specific test for Helicobacter pylori infection. Gastrointest. Endosc. 1991; 37: 550-1.
27. 27 Chen JS, Campbell TC, Li JY, Peto R. Diet, Life-style and Mortality in China. A study of the Characteristics of 65 Chinese Counties. Oxford: Oxford University Press, 1990.
28. 28 Correa P, Haenszel W, Cuello C. Gastric precancerous process in a high risk population: Cross-sectional studies. Cancer Res. 1990; 50: 4731-6.
29. 29 Wakabayashi K, Nagao M, Ochiai M, Tahira T, Yamaizuki Z, Sugimura T. A mutagenic precursor in Chinese cabbage, indole-3-acetonitrite, which becomes mutagenic on nitric acid treatment. Mutat. Res. 1985; 143: 17-21.
30. 30 Correa P. Human gastric carcinogenesis: A multistep and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992; 52: 6735-40.
31. 31 Sobala GM, Schorah CJ, Sanderson M et al. Ascorbic acid in the human stomach. Gastroenterology 1989; 97: 357-63.
32. 32 Davies GR, Simmonds NJ, Stevens TRJ et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-85.
33. 33 Wink DA, Kasprzak KS, Maragos CM et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001-3.
34. 34 Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl Acad. Sci. USA 1992; 89: 3030-4.
35. 35 Salmela KS, Roine RP, Koivisto T, Hook-Nikanne H, Kosunen TU, Salaspuro M. Characteristics of Helicobacter pylori alcohol dehydrogenase. Gastroenterology 1993; 105: 325-30.
36. 36 Xiang Z, Bugnoli M, Ponzetto A et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 1993; 12: 739-45.
37. 37 Crabtree JE, Wyatt JI, Sobala GM et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34: 1339-43.
38. 38 Hirai MJ, Azuma T, Ito S, Dato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int. J. Cancer 1994; 56: 56-60.
39. 39 Chen JS, Wong BCY, Wu YN et al. Preliminary analysis of dietary risk factors for precancerous gastric lesions in population of Changle, a high risk area of gastric cancer in China. Gastroenterology 1997; 112: A547.
40. 40 Munoz N, Kato I, Peraza S et al. Prevalence of precancerous lesions of the stomach in Venezuela. Cancer Epidemiol. Biomarkers Prev. 1996; 5: 41-6.
41. 41 Hu PJ, Li YY, Lin HL et al. Gastric atrophy and regional variation in upper gastrointestinal disease. Am. J. Gastroenterol. 1995; 90: 1102-6.